Al Altomari, Chairman and CEOAgile Therapeutics
Charlene Banard, Global Head of Technical Operations Cell & Gene Therapy Strategy, Innovation Pipeline and PMONovartis
Jeffrey Berkowitz, Board MemberH. Lundbeck A/S
Liz Bywater, Ph.D., PresidentBywater Consulting Group
Ron Cohen, M.D., President & CEOAcorda Therapeutics
Laurie Cooke, former CEOHealthcare Businesswomen's Association (HBA)
John Crowley, Chairman and CEOAmicus Therapeutics
Rich Daly, Chief Operating OfficerBeyond Spring
Raúl Díaz, Animal Health Large Molecules Biopharm. OperationsMSD, Montes Claros, MG, Brazil
Tom Dilenge, President, Advocacy, Law & Public Policy DivisionBiotechnology Innovation Organization
Joseph Ferra, CFOElevation Oncology
Anu Hans, VP, Strategic InitiativesJanssen Supply Chain
Fred Hassan, Managing DirectorWarburg Pincus
Paul Hastings, President and CEONkarta Therapeutics
Axel Hoos, M.D., Ph.D., CEOScorpion Therapeutics
John Hubbard, Ph.D., Emeritus Editorial Advisory Board MemberLife Science Leader
Mitchell Katz, Ph.D., Vice President, Development OperationsFerring Pharmaceutical, Inc.
Mary Rose Keller, VP, Head Of Clinical OperationsAcrivon Therapeutics
Rachel King, CEOGlycoMimetics
Suresh Kumar, Former EVP External AffairsSanofi
John LaMattina, Ph.D., Sr. PartnerPureTech Health
Jacks Lee, SVP Global Manufacturing and SupplyMerck
Martin Lehr, CEOContext Therapeutics
Sandy Macrae, Ph.D., President & CEOSangamo Therapeutics
Ken Moch, Former President & CEOCognition Therapeutics
Carol Nacy, Ph.D., CEOSequella
Francois Nader, M.D., Chairman of the BoardAcceleron Pharma
Sandra E. Poole, Chief Operating OfficerMythic Therapeutics
Dennis Purcell, Founder & Sr. AdvisorAisling Capital
David Pyott, Chairman of the BoardBioniz Therapeutics
Chandra Ramanathan, Ph.D., MBA, VP & Head, East Coast Innovation CenterBayer
Stephen Rapundalo, Ph.D., President & CEOMichBio
Pamela Reilly Contag, Ph.D., Cofounder and CEOBioEclipse Therapeutics
John Reynders, Ph.D., VP, R&D Strategy, Program Management, and Data SciencesAlexion
James Robinson, Emeritus Editorial Advisory Board MemberLife Science Leader
Tomasz Sablinski, M.D., Ph.D., Managing Director, Head of Clinical DevelopmentAuven Therapeutics
Jim Scibetta, CEOMaverick Therapeutics
Chhaya Shah, SVP Technical OperationsRadius Health
Allan Shaw, Independent Consultant
Brandi Simpson, VP Business and Corporate DevelopmentVoyager Therapeutics
Andrew Skibo, Emeritus Editorial Advisory Board Member, Life Science LeaderMedImmune / AstraZeneca
Jason Urban, Ph.D., Sr. Dir. Quality Risk ManagementAlexion
Thomas Wiggans, Founder, CEO, ChairmanDermira
Leslie Williams, Entrepreneur, Executive, Board Member, Mentor
Tim Wright, CEOMiMedx
ASK THE BOARD
- Could The New Way Of Working More Virtually Offer Opportunities To Break The Silo Mentality That Exists Within Organizations?
- What Is Your Opinion On The Practical Applications Of CRISPR Cas9 And Will We See A Commercial Application Of This Technology In The Next Decade?
- Gallup Reported That Millennials Want A Workplace That Cares About Employees’ Wellbeing. How Will We Engage The Millennials To Carry On, Or Will They Be Able To Change Pharma Culture?
- What Advice Do You Have For Getting Up To Speed On A New Discipline As A Leader (E.G., Your Move To Cell & Gene)?
- When Your Next Job Is A Step Back From Where You Were, How Do You Manage, And What Have Been Some Of The Valuable Lessons/Insights Gained From The Experience?
- What Is The Most Valuable Experience Gained From Your Military Training That Best Prepared You For Leading A Biopharma Company?
IN THIS MONTH'S ISSUE
-
Against All Odds: Advancing From R&D To Phase 37/1/2021
There is nothing more rewarding than knowing that we can help save a life and give hope to patients and their friends and families. Because lives are at stake, there must be more regulations and processes to ensure safety and efficacy.
-
Coming Out Of Stealth Mode: What To Know And Do7/1/2021
Five CEOs discuss their experiences with stealth mode transitions. They address when and how a company should turn away from that introspective state and show itself to the world.
-
The Collective Benefits Of A Collaborative CFO7/1/2021
Terry Coelho, CFO, works as a team member, not just a finance manager, at BioDelivery Sciences.
-
From Fusion Energy To Med Device … To Drug Developer?7/1/2021
TAE Life Sciences wanted to create a combination product that brought together its neutron beam with a drug that delivers boron to cancer cells. But, the company didn’t want to be in a position where it relied on another company for the drug needed.
BEYOND THE PRINTED PAGE
@LIFESCILEADER1
EVENTS
-
17th European Gastroenterology & Therapeutics Cong
July 26 - 27, 2021
-
Caregiving 101
July 27, 2021
-
5th International Conference on Surgery and Anaesthesia
July 28 - 29, 2021
-
HIPAA, 42 CFR Part 2, and FERPA - Rules for Managing Student Health Information
July 28, 2021
-
Overcoming Imposter syndrome
July 30, 2021
This website uses cookies to ensure you get the best experience on our website. Learn more